Arbuckle Stuart A 4
4 · Praxis Precision Medicines, Inc. · Filed Feb 10, 2026
Research Summary
AI-generated summary of this filing
Praxis (PRAX) Director Stuart Arbuckle Receives Equity Awards
What Happened
Stuart A. Arbuckle, a director of Praxis Precision Medicines (PRAX), received equity awards on February 6, 2026: 688 restricted stock units (RSUs), 478 RSUs, and 224 shares tied to an option/award — a total of 1,390 award units. All items were reported as acquired at $0 (compensation grants rather than cash purchases). The RSUs settle only by delivery of common stock; the 224-share award is a derivative with a short monthly vesting schedule.
Key Details
- Transaction date: February 6, 2026; filing date: February 10, 2026 (timely).
- Reported price: $0 for all awards (compensation grants).
- Total units granted: 1,390 (688 RSUs + 478 RSUs + 224 derivative/option units).
- Vesting highlights:
- 688 RSUs: vest in two equal annual installments on the first two anniversaries of January 8, 2026 (Jan 8, 2027 and Jan 8, 2028).
- 478 RSUs: single annual installment on the earlier of June 26, 2026 or the 2026 annual meeting.
- 224 derivative shares: vest in equal monthly installments on the 26th of each month from Feb 26, 2026 through the earlier of June 26, 2026 or the 2026 annual meeting.
- Shares owned after the transaction: not specified in the provided excerpt.
- Filing timeliness: Filed within the Form 4 deadline (no late filing flag).
Context
These awards are typical compensation grants (RSUs and a short-term vesting award) and do not involve an open-market purchase or sale. RSUs convert into shares when they vest and are normally used to retain or incentivize executives/directors. Such grants are informational about compensation but are not, by themselves, a direct bullish or bearish trading signal.
Insider Transaction Report
- Award
Common Stock
[F1]2026-02-06+688→ 688 total - Award
Common Stock
[F2]2026-02-06+478→ 1,166 total - Award
Stock Option (Right to Buy)
[F3]2026-02-06+224→ 224 totalExercise: $319.57Exp: 2036-02-06→ Common Stock (224 underlying)
Footnotes (3)
- [F1]Mr. Arbuckle was awarded 688 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vest in two equal annual installments occurring on the first two anniversaries of January 8, 2026. The restricted stock units may be settled only by delivering shares of the Issuer's common stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.
- [F2]Mr. Arbuckle was awarded 478 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vest in a single annual installment on the earlier of (i) June 26, 2026 or (ii) the date of the Issuer's 2026 annual meeting of stockholders. The restricted stock units may be settled only by delivering shares of the Issuer's common stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.
- [F3]The shares subject to this option shall vest in equal monthly installments occurring on the 26th day of each month, with the first such installment occurring on February 26, 2026 and the final such installment occurring on the earlier of (i) June 26, 2026 or (ii) the date of the Issuer's 2026 annual meeting of stockholders.